Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IPF”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03222648
What this trial is testing

Structured Exercise Training Programme in Idiopathic Pulmonary Fibrosis

Who this might be right for
BreathlessnessQuality of LifeIdiopathic Pulmonary Fibrosis
University Hospital Southampton NHS Foundation Trust 17
Not applicableStudy completedNCT03211507
What this trial is testing

Idiopathic Pulmonary Fibrosis Job Exposures Study

Who this might be right for
IPFIdiopathic Pulmonary Fibrosis
Imperial College London 960
Early research (Phase 1)Study completedNCT06569381
What this trial is testing

Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions

Who this might be right for
Idiopathic Pulmonary Fibrosis
Overseas Pharmaceuticals, Ltd. 18
Not applicableApproved For MarketingNCT02141087
What this trial is testing

Expanded Access Program (EAP): Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to Pirfenidone

Who this might be right for
Idiopathic Pulmonary Fibrosis
Genentech, Inc.
Not applicableUnknownNCT05635032
What this trial is testing

Fibrosing ILD Biomarkers That Rule Acceleration

Who this might be right for
Pulmonary FibrosisSarcoidosis
Universidade do Porto 150
Early research (Phase 1)Study completedNCT07229716
What this trial is testing

Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects

Who this might be right for
Pulmonary Fibrosis
Guangdong Hengrui Pharmaceutical Co., Ltd 20
Not applicableStudy completedNCT06563011
What this trial is testing

The Assessment of Nutritional Status of Patients With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
İrem Çağla Özel 31
Large-scale testing (Phase 3)Looking for participantsNCT07201922
What this trial is testing

Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

Who this might be right for
Familial Pulmonary FibrosisInterstitial Lung AbnormalitiesInterstitial Lung Diseases
Boehringer Ingelheim 80
Testing effectiveness (Phase 2)Temporarily pausedNCT05387239
What this trial is testing

Safety and Effectiveness of VL-PX10 + VL-P22 Treatment on Pulmonary Fibrosis Secondary to Covid-19

Who this might be right for
Pulmonary FibrosisCOVID-19 Respiratory Infection
Vitti Labs, LLC 20
Testing effectiveness (Phase 2)Study completedNCT00063869
What this trial is testing

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
Wyeth is now a wholly owned subsidiary of Pfizer 88
Not applicableLooking for participantsNCT07236541
What this trial is testing

Impact of Airway Mucus Plugs on Secondary Pulmonary Fibrosis in COPD Patients: A Single-Center Case-Control Study

Who this might be right for
Lung Fibrosis
Ming Zhong 20
Early research (Phase 1)Study completedNCT01725139
What this trial is testing

A Proof of Mechanism Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
GlaxoSmithKline 17
Testing effectiveness (Phase 2)Study completedNCT01529853
What this trial is testing

To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Sanofi 24
Not applicableUnknownNCT04019080
What this trial is testing

Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in Sweden

Who this might be right for
Idiopathic Pulmonary Fibrosis
Karolinska University Hospital 400
Testing effectiveness (Phase 2)Ended earlyNCT05032066
What this trial is testing

Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Amgen 153
Not applicableLooking for participantsNCT07743996
What this trial is testing

Emotional and Social Experiences of Antifibrotic (AF) Therapy Among Idiopathic Pulmonary Fibrosis (IPF)/Progressive Pulmonary Fibrosis (PPF) Patients: A Real-World Study

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis
Boehringer Ingelheim 100
Post-approval studies (Phase 4)Study completedNCT03503188
What this trial is testing

Digital Auscultation Test - IPF Data Collection

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 274
Testing effectiveness (Phase 2)Looking for participantsNCT07230288
What this trial is testing

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
AbbVie 165
Not applicableStudy completedNCT00692796
What this trial is testing

Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
National Jewish Health 60
Not applicableStudy completedNCT04996303
What this trial is testing

Efficacy of Steroid Pulse Therapy in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF) Admitted in ER

Who this might be right for
Idiopathic Pulmonary Fibrosis With Acute Exacerbation
Yonsei University 100
Next Page